HO-1 concentrations 24 hours after cardiac surgery are associated with the incidence of acute kidney injury: a prospective cohort study.

acute kidney injury cardiac surgery cardiopulmonary bypass heme oxygenase-1

Journal

International journal of nephrology and renovascular disease
ISSN: 1178-7058
Titre abrégé: Int J Nephrol Renovasc Dis
Pays: New Zealand
ID NLM: 101550217

Informations de publication

Date de publication:
2019
Historique:
entrez: 19 2 2019
pubmed: 19 2 2019
medline: 19 2 2019
Statut: epublish

Résumé

Acute kidney injury (AKI) is a serious complication after cardiac surgery that is associated with increased mortality and morbidity. Heme oxygenase-1 (HO-1) is an enzyme synthesized in renal tubular cells as one of the most intense responses to oxidant stress linked with protective, anti-inflammatory properties. Yet, it is unknown if serum HO-1 induction following cardiac surgical procedure involving cardiopulmonary bypass (CPB) is associated with incidence and severity of AKI. In the present study, we used data from a prospective cohort study of 150 adult cardiac surgical patients. HO-1 measurements were performed before, immediately after and 24 hours post-CPB. In univariate and multivariate analyses, the association between HO-1 and AKI was investigated. AKI with an incidence of 23.3% (35 patients) was not associated with an early elevation of HO-1 after CPB in all patients ( The association of the second HO-1 burst 24 hours after CBP might help to distinguish between the causality of AKI in patients undergoing CBP, thus helping to adapt patient stratification and management.

Sections du résumé

BACKGROUND BACKGROUND
Acute kidney injury (AKI) is a serious complication after cardiac surgery that is associated with increased mortality and morbidity. Heme oxygenase-1 (HO-1) is an enzyme synthesized in renal tubular cells as one of the most intense responses to oxidant stress linked with protective, anti-inflammatory properties. Yet, it is unknown if serum HO-1 induction following cardiac surgical procedure involving cardiopulmonary bypass (CPB) is associated with incidence and severity of AKI.
PATIENTS AND METHODS METHODS
In the present study, we used data from a prospective cohort study of 150 adult cardiac surgical patients. HO-1 measurements were performed before, immediately after and 24 hours post-CPB. In univariate and multivariate analyses, the association between HO-1 and AKI was investigated.
RESULTS RESULTS
AKI with an incidence of 23.3% (35 patients) was not associated with an early elevation of HO-1 after CPB in all patients (
CONCLUSION CONCLUSIONS
The association of the second HO-1 burst 24 hours after CBP might help to distinguish between the causality of AKI in patients undergoing CBP, thus helping to adapt patient stratification and management.

Identifiants

pubmed: 30774413
doi: 10.2147/IJNRD.S165308
pii: ijnrd-12-009
pmc: PMC6350641
doi:

Types de publication

Journal Article

Langues

eng

Pagination

9-18

Déclaration de conflit d'intérêts

Disclosure The authors report no conflicts of interest in this work.

Références

Crit Care Med. 2000 Mar;28(3):809-17
pubmed: 10752834
J Thorac Cardiovasc Surg. 2001 Mar;121(3):598
pubmed: 11241104
J Am Soc Nephrol. 2003 Mar;14(3):745-54
pubmed: 12595512
J Thorac Cardiovasc Surg. 2005 Feb;129(2):391-400
pubmed: 15678051
Ann Thorac Surg. 2005 Mar;79(3):825-9; author reply 829-30
pubmed: 15734386
J Clin Invest. 1992 Jul;90(1):267-70
pubmed: 1634613
Kidney Int. 2006 Aug;70(3):432-43
pubmed: 16775600
Anesth Analg. 2006 Jul;103(1):15-20, table of contents
pubmed: 16790618
J Cardiothorac Vasc Anesth. 2008 Dec;22(6):814-22
pubmed: 18948034
J Am Soc Nephrol. 2009 Jun;20(6):1172-4
pubmed: 19470671
Ann Thorac Surg. 2009 Jul;88(1):124-30
pubmed: 19559209
Am J Kidney Dis. 2009 Dec;54(6):1012-24
pubmed: 19850388
Perfusion. 2009 Sep;24(5):297-305
pubmed: 20007817
Eur J Cardiothorac Surg. 2011 Mar;39(3):323-8
pubmed: 20739188
Pediatr Res. 2011 May;69(5 Pt 1):378-83
pubmed: 21263376
Ann Thorac Surg. 2012 Feb;93(2):537-44
pubmed: 22197615
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
Interact Cardiovasc Thorac Surg. 2012 Jun;14(6):704-7
pubmed: 22434857
Nephron Clin Pract. 2012;120(4):c179-84
pubmed: 22890468
Clin Chem Lab Med. 2012 Feb 15;50(9):1505-17
pubmed: 22962216
Neth J Med. 2012 Dec;70(10):450-4
pubmed: 23230014
Circ Heart Fail. 2013 Jan;6(1):83-90
pubmed: 23230310
Acta Physiol (Oxf). 2013 Apr;207(4):663-72
pubmed: 23375078
Clin J Am Soc Nephrol. 2013 Sep;8(9):1482-93
pubmed: 23744003
J Thorac Cardiovasc Surg. 2014 Feb;147(2):800-7
pubmed: 24100099
Ann Thorac Surg. 2014 Jan;97(1):111-7
pubmed: 24119985
J Am Soc Nephrol. 2014 Mar;25(3):595-605
pubmed: 24503241
Cardiol Res Pract. 2014;2014:615987
pubmed: 24511410
PLoS One. 2014 Mar 27;9(3):e93460
pubmed: 24675717
PLoS One. 2014 May 14;9(5):e98028
pubmed: 24826910
Cardiorenal Med. 2014 Apr;4(1):12-21
pubmed: 24847330
Ann Thorac Surg. 2014 Jul;98(1):9-14; discussion 14-5
pubmed: 24881861
Ann Thorac Surg. 2014 Sep;98(3):815-22
pubmed: 25086946
J Cardiothorac Vasc Anesth. 2014 Dec;28(6):1448-52
pubmed: 25440657
Am J Kidney Dis. 2015 Feb;65(2):283-93
pubmed: 25445101
Crit Care. 2015 Jan 06;19:3
pubmed: 25560277
Oxid Med Cell Longev. 2015;2015:189863
pubmed: 25722792
Clin J Am Soc Nephrol. 2016 Jan 7;11(1):21-9
pubmed: 26576618
J Trauma Acute Care Surg. 2016 Feb;80(2):243-9
pubmed: 26816218
Am J Kidney Dis. 2016 Jul;68(1):19-28
pubmed: 26948834
Methods Inf Med. 2016 Aug 5;55(4):381-6
pubmed: 27405886
Am J Med. 2017 Feb;130(2):163-172.e4
pubmed: 27751901
Clin J Am Soc Nephrol. 2017 Jan 6;12(1):149-173
pubmed: 27827308
Nephrology (Carlton). 2018 Mar;23(3):237-246
pubmed: 27990707
Intensive Care Med. 2017 Nov;43(11):1551-1561
pubmed: 28110412
Kidney Int. 1995 Oct;48(4):1298-307
pubmed: 8569092

Auteurs

Attila Magyar (A)

Department of Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany, magyar_a@ukw.de.
Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, magyar_a@ukw.de.

Martin Wagner (M)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, magyar_a@ukw.de.
Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.
Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.

Phillip Thomas (P)

Department of Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany, magyar_a@ukw.de.
Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, magyar_a@ukw.de.

Carolin Malsch (C)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, magyar_a@ukw.de.

Reinhard Schneider (R)

Division of Nephrology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.

Stefan Störk (S)

Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
Division of Cardiology, Department of Medicine I, University Hospital Würzburg, Würzburg, Germany.

Peter U Heuschmann (PU)

Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, magyar_a@ukw.de.
Comprehensive Heart Failure Center, University of Würzburg, Würzburg, Germany.
Clinical Trial Center Würzburg, University Hospital Würzburg, Würzburg, Germany.

Rainer G Leyh (RG)

Department of Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany, magyar_a@ukw.de.

Mehmet Oezkur (M)

Department of Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany, magyar_a@ukw.de.
Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany, magyar_a@ukw.de.

Classifications MeSH